Medicine and Dentistry
Transcatheter Arterial Chemoembolization
100%
Neoplasm
63%
Hepatocellular Carcinoma
63%
Liver Cancer
26%
Liver Metastasis
24%
Cholangiocarcinoma
23%
Radiofrequency Ablation
22%
Embolization
22%
Oncology
21%
Magnetic Resonance Imaging
17%
Radioembolization
16%
Catheter Ablation
16%
Surgery
15%
Interventional Radiology
15%
Yttrium 90
14%
Overall Survival
14%
Intraarterial Drug Administration
14%
Arterial Embolization
13%
Disease
13%
Computer Assisted Tomography
13%
Obesity Medicine
12%
Inferior Vena Cava Filter
12%
Liver Graft
12%
Malignant Neoplasm
12%
Liver Tumor
12%
Cryoablation
12%
Endoscopy
12%
Ablation Therapy
11%
Neuroendocrine Tumor
11%
Adverse Event
11%
Biliary Tract Endoscopy
11%
Biopsy
10%
Biological Marker
9%
Cancer
9%
Arm
9%
Health Care Cost
8%
Surgeon
8%
Diagnosis
8%
Clear Cell Renal Cell Carcinoma
8%
Medicare
8%
Vascular Tissue Neoplasm
8%
Radiology
8%
Quality of Life
8%
Pulmonary Embolism
8%
Primary Hyperaldosteronism
7%
Lipiodol
7%
Artery
7%
Microsphere
7%
Cancer Staging
7%
Fluoroscopy
6%
Keyphrases
Transarterial Chemoembolization
38%
Hepatocellular Carcinoma
29%
Chemoembolization
27%
Radiofrequency Ablation
17%
Enhancing Tumor
16%
Tumor
15%
Intra-arterial Therapy
13%
Intrahepatic Cholangiocarcinoma (iCCA)
13%
Interventional Radiology
12%
Transcatheter Arterial Chemoembolization
11%
Interventional Oncology
11%
Tumor Burden
11%
Overall Survival
10%
Liver Transplantation
10%
Arterial Embolization
10%
Clinical Outcomes
9%
Hepatocellular Carcinoma Patients
9%
Liver Cancer
9%
Propensity Score
9%
Single Center
8%
Bariatric
8%
Drug-eluting Beads Transarterial Chemoembolization (DEB-TACE)
8%
Unresectable Cholangiocarcinoma
8%
Geometric Calibration
8%
Doxorubicin
8%
Neuroendocrine Tumor Liver Metastases
8%
Obesity
8%
Inferior Vena Cava Filter
8%
Tumor Response
8%
Three-dimensional (3D)
7%
Adrenal Vein Sampling
7%
Barcelona Clinic Liver Cancer
7%
Tumor Size
7%
Weight Loss
7%
Primary Liver Cancer
7%
Confidence Interval
7%
Non-responders
6%
Patient Survival
6%
Retrospective Analysis
6%
Contrast Enhancement
6%
Embosphere Microsphere
6%
Tumor Volume
6%
Tumor Enhancement
6%
Adverse Events
5%
Conventional Transarterial Chemoembolization (cTACE)
5%
Percutaneous Ablation
5%
Functional Magnetic Resonance Imaging
5%
Catheter-related
5%
Cholangiocarcinoma
5%
Drug-eluting Beads
5%